
Angiogenèse
Sous-catégories appartenant à la catégorie "Angiogenèse"
- BTK(167 produits)
- Bcr-Abl(118 produits)
- EGFR(581 produits)
- FAK(72 produits)
- FLT(86 produits)
- Récepteur du facteur de croissance des fibroblastes (FGFR)(180 produits)
- JAK(243 produits)
- PDGFR(129 produits)
- RAAS(89 produits)
- Src(82 produits)
- Syk(37 produits)
- Thrombine(57 produits)
- VDA(2 produits)
- VEGFR(242 produits)
2382 produits trouvés pour "Angiogenèse"
CEP-33779
CAS :CEP-33779 is a novel and selective inhibitor of JAK2 with an IC50 of 1.8±0.6 nM.Formule :C24H26N6O2SDegré de pureté :98.24% - ≥95%Couleur et forme :SolidMasse moléculaire :462.57Ref: TM-T6122
1mg43,00€2mg56,00€5mg93,00€10mg137,00€25mg231,00€50mg356,00€100mg530,00€500mg1.153,00€1mL*10mM (DMSO)92,00€Atopaxar hydrochloride
CAS :Atopaxar hydrochloride is used in the Treatment of Cardiovascular Disorders.Formule :C29H39ClFN3O5Couleur et forme :SolidMasse moléculaire :564.1Afatinib Dimaleate
CAS :Afatinib Dimaleate (BIBW 2992MA2) is an orally bioavailable anilino-quinazoline derivative and inhibitor of the EGFR family, with antineoplastic activity.Formule :C32H33ClFN5O11Degré de pureté :98.11% - 99.87%Couleur et forme :SolidMasse moléculaire :718.08Olmutinib hydrochloride
CAS :Olmutinib is a third-gen EGFR inhibitor for T790M-positive lung cancer, blocking phosphorylation and tumor pathways. Approved in Korea (2016).Formule :C26H28Cl2N6O2SCouleur et forme :SolidMasse moléculaire :559.51SKLB1002
CAS :SKLB1002 is a potent and ATP-competitive VEGFR2 inhibitor with IC50 of 32 nM.Formule :C13H12N4O2S2Degré de pureté :98.51% - >99.99%Couleur et forme :SolidMasse moléculaire :320.39Fedratinib
CAS :Fedratinib (TG-101348) (TG101348) is an ATP-competitive inhibitor of JAK2 (IC50: 3 nM) with significantly less potent activity against JAK3.Formule :C27H36N6O3SDegré de pureté :97.31% - 99.96%Couleur et forme :SolidMasse moléculaire :524.68Ref: TM-T1995
1g592,00€5mg50,00€10mg65,00€50mg107,00€100mg127,00€200mg205,00€500mg447,00€1mL*10mM (DMSO)54,00€Sitravatinib
CAS :Sitravatinib (MGCD516) (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα/β, PDGFR, andFormule :C33H29F2N5O4SDegré de pureté :98.9% - 99.85%Couleur et forme :SolidMasse moléculaire :629.68Ref: TM-T4349
5mg49,00€10mg74,00€25mg130,00€50mg200,00€100mg319,00€200mg507,00€500mg800,00€1mL*10mM (DMSO)69,00€VEGFR-2-IN-5
CAS :VEGFR-2-IN-5 (UNC0064-12), multikinase inhibitor and has a -NH2 terminal linker for further synthesis.Formule :C19H24N8Degré de pureté :99.92%Couleur et forme :SolidMasse moléculaire :364.45Ref: TM-T2056
1mg90,00€5mg222,00€10mg333,00€25mg560,00€50mg797,00€100mg1.071,00€1mL*10mM (DMSO)224,00€HA 155
CAS :HA 155 (Autotaxin Inhibitor IV) is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine.Formule :C24H19BFNO5SDegré de pureté :99.88%Couleur et forme :SolidMasse moléculaire :463.29OSI-930
CAS :OSI-930 is an oral c-Kit/VEGFR-2 inhibitor targeting tumor growth and angiogenesis.Formule :C22H16F3N3O2SDegré de pureté :99.67%Couleur et forme :SolidMasse moléculaire :443.44Deucravacitinib
CAS :Deucravacitinib (BMS-986165) is a highly selective, orally bioavailable, allosteric TYK2 inhibitor.Cost-effective and quality-assured.Formule :C20H19D3N8O3Degré de pureté :98.52% - >99.99%Couleur et forme :SolidMasse moléculaire :425.46Ref: TM-T14687
1mg56,00€5mg137,00€10mg248,00€25mg389,00€50mg575,00€100mg817,00€1mL*10mM (DMSO)149,00€Ensartinib
CAS :Ensartinib (X-396) is a potent and orally active dual ALK/MET inhibitor for the treatment of ALK-positive non-small cell lung cancer (NSCLC).Formule :C26H27Cl2FN6O3Degré de pureté :99.92%Couleur et forme :SolidMasse moléculaire :561.44Ensartinib hydrochloride
CAS :Ensartinib hydrochloride (X-396 dihydrochloride) is a potent new-generation ALK inhibitor with high activity against CNS metastases and a broad range of knownFormule :C26H29Cl4FN6O3Degré de pureté :98.73%Couleur et forme :SolidMasse moléculaire :634.36Ref: TM-T22324
1mg54,00€5mg114,00€10mg177,00€25mg356,00€50mg580,00€100mg888,00€1mL*10mM (DMSO)158,00€Momelotinib
CAS :Momelotinib (LM-1149), an oral JAK1/2 inhibitor with IC50s 11/18 nM, blocks ATP binding, disrupting JAK-STAT pathway and reducing tumor growth.Formule :C23H22N6O2Degré de pureté :97.07% - 99.56%Couleur et forme :SolidMasse moléculaire :414.46Ref: TM-T1849
1mg35,00€2mg50,00€5mg77,00€10mg89,00€25mg158,00€50mg245,00€100mg385,00€200mg592,00€1mL*10mM (DMSO)84,00€TAK-659 hydrochloride
CAS :TAK-659 hydrochloride (TAK-659) is a potent and selective inhibitor of spleen tyrosine kinase (SYK) with an IC50 value of 3.2 nM.Formule :C17H22ClFN6ODegré de pureté :99.28% - 99.82%Couleur et forme :SolidMasse moléculaire :380.85AST 487
CAS :AST 487 (NVP-AST 487) is a RET kinase inhibitor, inhibiting RET autophosphorylation and activation of downstream effectors. It also can inhibit Flt-3.Formule :C26H30F3N7O2Degré de pureté :98.17% - 99.56%Couleur et forme :SolidMasse moléculaire :529.56Ref: TM-T4053
1mg34,00€2mg49,00€5mg74,00€10mg113,00€25mg177,00€50mg334,00€100mg500,00€500mg1.099,00€1mL*10mM (DMSO)87,00€SB1317 hydrochloride (1204918-72-8(free base))
SB1317 hydrochloride (1204918-72-8(free base)) (TG-02 hydrochloride) is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).Formule :C23H25ClN4ODegré de pureté :99.84%Couleur et forme :SolidMasse moléculaire :408.92Ref: TM-T4227
1mg50,00€2mg65,00€5mg107,00€10mg170,00€25mg306,00€50mg371,00€100mg553,00€1mL*10mM (DMSO)117,00€KRCA-0008
CAS :KRCA-0008 is an effective and specific ALK/Ack1 inhibitor (IC50: 12/4 nM); displays drug-like properties without hERG liability.Formule :C30H37ClN8O4Degré de pureté :96.19%Couleur et forme :SolidMasse moléculaire :609.12OICR-9429
CAS :OICR-9429 blocks WDR5 binding to MLL/Histone 3, hindering acute myeloid leukemia cell growth in vitro.Formule :C29H32F3N5O3Degré de pureté :97.07% - 99.93%Couleur et forme :SolidMasse moléculaire :555.59Ref: TM-T6916
1mg34,00€2mg49,00€5mg71,00€10mg105,00€25mg177,00€50mg295,00€100mg475,00€1mL*10mM (DMSO)92,00€Vatalanib dihydrochloride
CAS :Vatalanib dihydrochloride (PTK787 dihydrochloride)(IC50=37 nM) is an inhibitor of VEGFR2/KDR.Formule :C20H15ClN4·2HClDegré de pureté :99.16%Couleur et forme :White To Off-White Crystalline PowderMasse moléculaire :419.73BX-912
CAS :BX-912 inhibits PDK1 with IC50 of 12 nM; over 10x more selective versus C-Kit, EGFR, PKA, PKC.Formule :C20H23BrN8ODegré de pureté :98.29% - 99.34%Couleur et forme :SolidMasse moléculaire :471.35Ref: TM-T1837
1mg50,00€2mg71,00€5mg85,00€10mg137,00€25mg281,00€50mg470,00€100mg632,00€1mL*10mM (DMSO)88,00€Tivozanib hydrochloride hydrate
CAS :Tivozanib hydrochloride hydrate (AV-951 hydrochloride hydrate) is a VEGFR tyrosine kinase inhibitor that inhibits VEGFR-1, VEGFR-2, VEGFR-3 .Formule :C22H22Cl2N4O6Degré de pureté :98.66% - 99.99%Couleur et forme :SolidMasse moléculaire :509.34Cpd27
CAS :Cpd27 (TIE-2/VEGFR-2 kinase-IN-2) is a TIE-2 and VEGFR-2 inhibitor that inhibits RIPK1 and can be used to study glaucoma.Formule :C20H13F4N5O2Degré de pureté :98.89%Couleur et forme :SolidMasse moléculaire :431.34Bosutinib hydrate
CAS :Bosutinib hydrate (SKI-606 hydrate) is a kinase inhibitor of BCR-ABL and Src tyrosine kinases for the study of leukemia.Formule :C26H31Cl2N5O4Degré de pureté :99.87%Couleur et forme :SolidMasse moléculaire :548.46SB 203580 hydrochloride
CAS :SB 203580 hydrochloride (Adezmapimod hydrochloride) is a p38 MAPK inhibitor that induces mitochondrial autophagy and cytosolic autophagy.Formule :C21H17ClFN3OSDegré de pureté :97.79%Couleur et forme :SolidMasse moléculaire :413.9Donafenib
CAS :Donafenib(Bay 43-9006 (D3)) is a deuterium-labeled Sorafenib which is a multikinase inhibitor(IC50s: 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3,Formule :C21H13ClD3F3N4O3Degré de pureté :99.88%Couleur et forme :SolidMasse moléculaire :467.84Ref: TM-T16909
1mg87,00€5mg178,00€10mg321,00€25mg532,00€50mg770,00€100mg1.035,00€1mL*10mM (DMSO)192,00€GS-829845
CAS :GS-829845 is a JAK1 inhibitor, the main component of the active metabolite of Filgotinib, which is approximately 10-fold less potent and has a longer half-lifeFormule :C17H19N5O2SDegré de pureté :99.93%Couleur et forme :SolidMasse moléculaire :357.43Pulsatilla Saponin D (90%)
CAS :Produit contrôléApplications Pulsatilla Saponin D shows antiangiogenic and antitumor activity.
References Sang-Won, H. et al.: Carcinogen., 34, 2156 (2013);Formule :C47H76O17Degré de pureté :90%Couleur et forme :NeatMasse moléculaire :913.1Toceranib
CAS :Toceranib phosphate, orally active, inhibits RTK, PDGFR, VEGFR, Kit; Kis 5 nM PDGFRβ, 6 nM KDR; has antitumor effects.Formule :C22H25FN4O2Degré de pureté :97.62%Couleur et forme :SolidMasse moléculaire :396.46Cerdulatinib hydrochloride
CAS :Cerdulatinib hydrochloride is an oral tyrosine kinase inhibitor targeting JAK1/2/3, TYK2, Syk, and 19 others with IC50 < 200 nM.Formule :C20H28ClN7O3SDegré de pureté :99.85%Couleur et forme :SolidMasse moléculaire :482Osunprotafib
CAS :Osunprotafib (ABBV-CLS-484) is a potent, orally bioavailable PTP1B/PTPN2 inhibitor in clinical trials for solid tumors.Cost-effective and quality-assured.Formule :C17H24FN3O4SDegré de pureté :97.11% - 99.91%Couleur et forme :SolidMasse moléculaire :385.45Anumigilimab
CAS :Anumigilimab (CSL-324) is a fully human therapeutic anti-G-CSFR antibody with potential anti-tumor activity for the study of inflammation.Degré de pureté :95.75% (SEC-HPLC) - 98.43% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :143.86 kDaTG 100801
CAS :TG 100801 is a dual inhibitor of VEGFr2 and Src family kinases and is a candidate compound for the treatment of age-related macular degeneration (AMD).Formule :C33H30ClN5O3Degré de pureté :99.28% - 99.61%Couleur et forme :SolidMasse moléculaire :580.08Tirabrutinib
CAS :Tirabrutinib, an oral Btk inhibitor (IC50=6.8 nM), crosses the BBB and halts B cell signaling for autoimmune and hematologic studies.
Formule :C25H22N6O3Degré de pureté :99.64%Couleur et forme :SolidMasse moléculaire :454.48N-Acryloyl Osimertinib (>85%)
CAS :Applications N-Acryloyl Osimertinib is used in the preparation of pyrimidinyl indole derivative as EGFR inhibitor for targeted therapy of cancer
References Rao, Y., et al.: Faming Zhuanli Shenqing (2016), CN 105777716 A 20160720Formule :C31H35N7O3Degré de pureté :>85%Couleur et forme :Off White SolidMasse moléculaire :553.65PDGFR Tyrosine Kinase Inhibitor III
CAS :PDGFR Tyrosine Kinase Inhibitor III (PDGF Receptor Tyrosine Kinase Inhibitor III) (PDGF Receptor Tyrosine Kinase Inhibitor III) is a multikinase inhibitor thatFormule :C27H27N5O4Degré de pureté :99.50%Couleur et forme :SoildMasse moléculaire :485.53CCT241161
CAS :CCT241161: oral pan-RAF inhibitor; IC50s: LCK (3 nM), CRAF (6), SRC (10), V600E-BRAF (15), BRAF (30); fights BRAF/NRAS melanomas, anti-proliferative.Formule :C28H27N7O3SDegré de pureté :99.76% - 99.77%Couleur et forme :SolidMasse moléculaire :541.62Clopidogrel Related Compound B
CAS :Impurity Clopidogrel Impurity B; Clopidogrel USP B; Clopidogrel USP Related Compound B
Applications Clopidogrel Related Compound B (Clopidogrel Impurity B; Clopidogrel USP B; Clopidogrel USP Related Compound B) is a tetrahydrothienopyridine as inhibitor of angiogenesis.
References Maffrand, J. P., et al.: Eur. J. Med. Chem., 9, 483 (1974), Thebault, J.J., et al.: Clin. Pharmacol. Ther., 18, 485 (1975),Formule :C16H16ClNO2S·ClHCouleur et forme :NeatMasse moléculaire :358.28Gefitinib hydrochloride
CAS :Obtustatin triacetate is an integrin derived from the venom of Vipera lebetina obtusa and is an α1β1 integrin and in vivo angiogenesis inhibitor.Formule :C22H25Cl2FN4O3Degré de pureté :99.8%Couleur et forme :SolidMasse moléculaire :483.36AZ 12799734
CAS :AZ 12799734 is an orally active, selective and potent dual inhibitor of TGFBR1 and ALK5 with inhibitory effects on BMP and TGFβ for the study of tumours.Formule :C18H18N4O3SDegré de pureté :98.23%Couleur et forme :SolidMasse moléculaire :370.43SB-505124 hydrochloride
CAS :SB-505124 hydrochloride (SB505124 hydrochloride) is a TGF-β type I receptor (ALK4, ALK5, ALK7) inhibitor for the study of colorectal cancer.Formule :C20H22ClN3O2Degré de pureté :98.71%Couleur et forme :SolidMasse moléculaire :371.86GSK1904529A
CAS :GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) .Formule :C44H47F2N9O5SDegré de pureté :98.2% - 99.76%Couleur et forme :SolidMasse moléculaire :851.96Alpha-Eudesmol
CAS :Applications α-Eudesmol is an isomer of β-Eudesmol (E938600), a sesquiterpenoid known to induce neurite outgrowth. β-Eudesmol exhibits antiangiogenic activity.
References Obara, Y. et al.: J. Pharmacol. Exp . Ther., 30, 803 (2011); Tsuneki, H. et al.: Eur. J. Pharmacol., 512, 105 (2005);Formule :C15H26OCouleur et forme :White To Off-WhiteMasse moléculaire :222.373,3-Azo-1-butanol
CAS :Produit contrôléFormule :C4H8N2OCouleur et forme :NeatMasse moléculaire :100.12Seribantumab
CAS :Seribantumab (MM 121) is a humanized monoclonal antibody targeting HER3, inhibiting cancer cell proliferation.Degré de pureté :>95%Couleur et forme :LiquidMasse moléculaire :143.14 kDaItacnosertib
CAS :Itacnosertib (TP-0184) is an orally available ACRV1 (ALK-2), FLT3 and JAK2 inhibitor that inhibits the growth of tumor cells,antitumor and antileukemic.Formule :C26H28N8ODegré de pureté :99.38%Couleur et forme :SolidMasse moléculaire :468.55Ref: TM-T39104
1mg92,00€5mg192,00€10mg313,00€25mg595,00€50mg888,00€100mg1.234,00€200mg1.665,00€1mL*10mM (DMSO)212,00€Glycerol 1-Monobutyrate (Technical Grade)
CAS :Applications Glycerol 1-Monobutyrate functions as a key regulatory molecule in angiogenic process.
References Dobson, D. E., et al.: Cell (Cambridge, MA, U. S.), 61, 223 (1990)Formule :C7H14O4Couleur et forme :NeatMasse moléculaire :162.18Dapolsertib
CAS :Dapolsertib (SEL24-B489) is an orally active and efficient PIM and FLT3-ITD inhibitor, reducing PIM-specific substrate phosphorylation.Formule :C15H18Br2N4O2Degré de pureté :99.61%Couleur et forme :SolidMasse moléculaire :446.14FAK activator 1
CAS :ZINC40099027 is a FAK activator that induces gastric mucosal repair in persistent aspirin-associated gastric injury.Formule :C23H26F3N3O3Degré de pureté :99.19%Couleur et forme :SoildMasse moléculaire :449.47Ref: TM-T77665
1mg94,00€5mg217,00€10mg362,00€25mg594,00€50mg952,00€100mg1.506,00€200mg1.969,00€1mL*10mM (DMSO)281,00€Cavutilide
CAS :Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.Formule :C22H26FN3O3Degré de pureté :99.82% - 99.85%Couleur et forme :SolidMasse moléculaire :399.458Syk Inhibitor II
CAS :Syk inhibitor II, a cell-permeable, ATP-competitive, pyrimidine-carboxamide compound, selectively and reversibly inhibits Syk (IC50 = 41 nM).Formule :C14H15F3N6ODegré de pureté :97.63%Couleur et forme :SolidMasse moléculaire :340.3Gefitinib-d6
CAS :Gefitinib-d6 is a deuterated compound of Gefitinib. Gefitinib has a CAS number of 184475-35-2. Gefitinib is an EGFR tyrosine kinase inhibitor and can inhibit Tyr1173, Tyr992, Tyr1173 and Tyr992 (IC50s: 37/37/26/57 nM).Formule :C22H18D6ClFN4O3Couleur et forme :SolidMasse moléculaire :452.94(Rac)-SAR131675
CAS :(Rac)-SAR131675 is an effective and specific VEGFR-3 inhibitor, which inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylation in HEK cells.Formule :C18H22N4O4Degré de pureté :98.73% - 99.1%Couleur et forme :SolidMasse moléculaire :358.39Naquotinib mesylate
CAS :Naquotinib mesylate (ASP8273 (mesylate)) is an orally available, mutant-selective and irreversible inhibitor of EGFR(iC50s of 8-33 nM and 230 nM for toward EGFRFormule :C31H46N8O6SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :658.81Canertinib dihydrochloride
CAS :Canertinib dihydrochloride (PD-183805 dihydrochloride) is the hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic andFormule :C24H27Cl3FN5O3Degré de pureté :99.13% - >99.99%Couleur et forme :SolidMasse moléculaire :558.86PF-03814735
CAS :PF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50of 0.8 nM/5 nM, is less potent to Flt3, FAK, TrkA, and minimally active to Met and FGFR1. Phase 1.Formule :C23H25F3N6O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :474.48Almonertinib hydrochloride
CAS :Almonertinib hydrochloride (HS-10296 hydrochloride) is a small molecule inhibitor of EGFR-activating mutations and T790M-resistant mutation.Formule :C30H36ClN7O2Degré de pureté :98.01% - 98.12%Couleur et forme :SolidMasse moléculaire :562.1BIBF 1202
CAS :BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).Formule :C30H31N5O4Degré de pureté :98.04%Couleur et forme :SolidMasse moléculaire :525.6Brivanib (alaninate)
CAS :Brivanib Alaninate (BMS-582664) is an alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic effect.Formule :C22H24FN5O4Degré de pureté :99.46% - 99.66%Couleur et forme :SolidMasse moléculaire :441.46BMS-690514
CAS :BMS-690514 is a potent and orally active inhibitor of EGFR and VEGFR. It has IC50s of 5, 20 and 60 nM for EGFR, HER 2 and HER 4, respectively.Formule :C19H24N6O2Degré de pureté :99.08%Couleur et forme :SolidMasse moléculaire :368.43NVP-BSK805
CAS :NVP-BSK805 (BSK 805) is an ATP-competitive JAK2 inhibitor.Formule :C27H28F2N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :490.55Methyl 6-[[[(2-Chloroethyl)amino]carbonyl]amino]-6-deoxy-α-D-glucopyranoside
CAS :Produit contrôléFormule :C10H19ClN2O6Couleur et forme :NeatMasse moléculaire :298.72Behenamide
CAS :Produit contrôléApplications Behenamide is a fatty acid amide as an angiogenic. The mechanism of angiogenic activity is unknown and this lipid does not promote proliferation of endothelial cells or induce inflammatory effects.
References Wakamatsu, K., et al.: Biochem. Biophysical Res. Comm., 168, 423 (1990),Formule :C22H45NOCouleur et forme :White To Off-WhiteMasse moléculaire :339.6(5E)-5-(4-Hydroxybenzylidene)-1,3-thiazolidine-2,4-dione
CAS :Produit contrôléApplications 5-[(4-Hydroxyphenyl)methylene]-2,4-thiazolidinedione is a 5-Benzylidene-2,4-thiazolidenedione derivative designed as inhibitors of angiogenesis targeting VEGFR-2. Also, it is an intermediate used in the synthesis of MSDC 0602 (M755420), which is an analogue of thiazolidinediones, exhibits low affinity for binding and activation of peroxisome proliferator-activated receptor γ (PPARγ). Thiazolidinediones are effective insulin-sensitizing drugs for treating various metabolic and inflammatory diseases.
References Bhanushali, U., et al.: Bioorg. Chem., 67, 139-147 (2016); Chen, Z., et al.: J. Biol. Chem. 287, 23537 (2012); Fukunaga, T., et al.: J. Bone Miner. Res., 30, 508 (2015)Formule :C10H7NO3SCouleur et forme :NeatMasse moléculaire :221.23Bafisontamab
CAS :Bafisontamab (EMB-01) is a bispecific antibody that targets EGFR and cMET, displaying antitumor activity [1].Couleur et forme :LiquidTovetumab
CAS :Tovetumab (MEDI-575) is an anti-PDGFRα mAb inhibiting its signaling, in trials for glioblastoma and NSCLC.Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :144.78 kDaIvonescimab
CAS :Ivonescimab (AK112) is a PD-1/VEGF bispecific antibody with cancer immunotherapy and anti-angiogenic effects, NSCLC).Degré de pureté :95% - >95.0% (SDS-PAGE); 98.99% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :201.12 kDaTarcocimab
CAS :Tarcocimab (OG1953) is a humanized IgG1 monoclonal antibody targeting VEGFA, researched for RVO and wet AMD.Couleur et forme :LiquidImgatuzumab
CAS :Imgatuzumab (RG 7160) is a humanized anti-EGFR monoclonal antibody and immunomodulator for cancer research.
Couleur et forme :LiquidMasse moléculaire :145.0 (kDa)Solrikitug
CAS :Solrikitug,Anti-CRLF2 humanized IgG1κ monoclonal antibody.Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :~150 kDaEGFR T790M/L858R-IN-8
CAS :EGFRT790M/L858R-IN-8 (compound 9) is a potent inhibitor of EGFR, specifically targeting the EGFRT790M/L858R mutations with an IC50 of 56.8 μM. This compound does not show significant antiproliferative effects on cancer cell lines A549, A431, and NHI-H1975.Formule :C16H11BrN2O3Couleur et forme :SolidMasse moléculaire :359.17Vanucizumab
CAS :Vanucizumab is a bispecific humanised monoclonal antibody that simultaneously inhibits the receptor interactions of VEGF-A and Angiopoietin-2 (Ang-2)Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :146.89 kDaElgemtumab
CAS :Elgemtumab (LJM716) is a fully humanised monoclonal antibody targeting HER3/ERBB3, acting as an antagonist to block HER3/Akt phosphorylation antitumour.Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :144.15 kDaZalutumumab
CAS :Zalutumumab is a high-affinity fully human monoclonal antibody ,the extracellular domain of the EGFR squamous cell carcinoma of the head and neck (SCCHN).Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :146.63 kDaSerclutamab
CAS :Serclutamab, a humanized chimeric monoclonal antibody of the IgG1-κ isotype, selectively targets the epidermal growth factor receptor (EGFR).Degré de pureté :98%Couleur et forme :LiquidAnti-Mouse VEGFR-2 Antibody (DC101)
Anti-Mouse VEGFR-2 Antibody (DC101) is a rat-derived monoclonal antibody against mouse VEGFR2/KDR/Flk-1, serving as a mouse analogue of ramucirumab.Degré de pureté :99%Couleur et forme :LiquidMasse moléculaire :150 kDaBecotatug
CAS :Becotatug (JMT101) is a humanised monoclonal antibody targeting EGFR, antitumour when combined with Osimertinib for treating EGFR-mutated advanced NSCLC.Degré de pureté :95% - 99.1% (SDS-PAGE); 98.1% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :145.52 kDaIzalontamab
CAS :Izalontamab (SI-B001) is a bispecific EGFR/HER3 monoclonal antibody that binds to both EGFR×EGFR homodimers and EGFR×HER3 heterodimers.Degré de pureté :95%+ - 95.3% (SDS-PAGE); 99.2% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :197.21 kDaDilpacimab
CAS :Dilpacimab (ABT165) is a dual-variable antibody that targets DLL4 and VEGF pathways, showing potential in cancer research by blocking angiogenesis and Notch.Degré de pureté :95% - 97.7% (SDS-PAGE); 95.6% (SEC-HPLC)Couleur et forme :LiquidAnbenitamab
CAS :Anbenitamab (KN-026) is a bispecific HER2 antibody for metastatic breast cancer research, blocking HER2 pathways and mediating ADCC.Couleur et forme :LiquidPonezumab
CAS :Ponezumab (PF-04360365), a humanized IgG2 antibody, lowers Aβ in the CNS & boosts mice memory. Used in Alzheimer's research.Couleur et forme :LiquidFidasimtamab
CAS :Fidasimtamab, a recombinant human IgG1 bispecific antibody, targets both HER2 and PD-1, bridging T cells and tumor cells to modulate immune responses.Degré de pureté :95% - 98.0% (SDS-PAGE); 98.3% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :144.72 kDaFaricimab
CAS :Faricimab,Bispecific antibody targeting Ang-2/VEGF-A. Prevents retinal I/R injury. Improves vision in w-AMD, DME, RVO.Degré de pureté :>95% (SDS-PAGE); >95% (SEC-HPLC) - >95% (SDS-PAGE); >95% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :146 kDaFutuximab
CAS :Futuximab is a chimeric monoclonal antibody targeting EGFR, commonly used in combination with zatuximab to form Sym004.Degré de pureté :95% - 97.5% (SDS-PAGE); 96.3% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :146.28 kDaIbrutinib-d5
CAS :Ibrutinib D5 is a deuterium-labeled Ibrutinib. Ibrutinib is an irreversible Btk inhibitor.Formule :C25H24N6O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :445.53Dasatinib-d8
CAS :Dasatinib D8 is deuterium-labeled dasatinib. Dasatinib is a dual Bcr-Abl and Src family tyrosine kinase inhibitor.Formule :C22H26ClN7O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :496.06Apatinib-d8
CAS :Apatinib-d8 is a deuterated compound of Apatinib. Apatinib has a CAS number of 811803-05-1. Apatinib is an orally bioavailable and specific VEGFR2 inhibitor (IC50: 1 nM). In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases.Formule :C24H15D8N5OCouleur et forme :SolidMasse moléculaire :405.52MAPK-IN-2
MAPK-IN-2 (compound 3h) is an efficacious MAPK inhibitor with antineoplastic properties that significantly hinders proliferation across various cancer cellFormule :C20H11Cl2N3ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :380.23Dovitinib Dilactic Acid
CAS :Dovitinib dilactic acid: multitarget RTK inhibitor for FLT3/c-Kit (IC50=1-2 nM), FGFR1/3, VEGFR1-4 (IC50=8-13 nM), less effective on InsR, EGFR. Phase 4.Formule :C21H21FN6O·2C3H6O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :572.59ALK5-IN-79
CAS :ALK5-IN-79 (compound 57), an ALK inhibitor, exhibits anticancer activity by inhibiting the TGF-β1/SMAD signaling pathway. It effectively reduces the production of extracellular matrix (ECM) and collagen deposition. Moreover, ALK5-IN-79 demonstrates satisfactory pharmacokinetic (PK) properties and favorable in vivo tolerance.Formule :C23H27N7OCouleur et forme :SolidMasse moléculaire :417.51ALKBH5-IN-3
CAS :ALKBH5-IN-3 (Compound 20m) is a selective ALKBH5 inhibitor (IC50=21 nM), effectively stabilizes ALKBH5 in HepG2 cells and elevates m6A levels in intact cells.Formule :C11H7F3N2O3Degré de pureté :98.32%Couleur et forme :SolidMasse moléculaire :272.18ZM323881 hydrochloride
CAS :ZM323881 hydrochloride (ZM 323881 HCl) is a potent and selective VEGFR2 inhibitor.Formule :C22H19ClFN3O2Degré de pureté :99.43%Couleur et forme :SolidMasse moléculaire :411.86Ref: TM-T1991
1mg34,00€5mg66,00€10mg96,00€25mg225,00€50mg369,00€100mg550,00€200mg780,00€1mL*10mM (DMSO)69,00€Erlotinib mesylate
CAS :Erlotinib: reversible inhibitor binding to ATP site of epidermal growth factor receptor.Formule :C23H27N3O7SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :489.54(3S,4S)-Tofacitinib
CAS :(3S,4S)-Tofacitinib, a less active enantiomer of tofacitinib, is a Janus kinases inhibitor.Formule :C16H20N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :312.37EGFR-IN-117
CAS :EGFR-IN-117 (Compound 8h) exhibits inhibitory activity against EGFR mutations, specifically targeting the tumor environment and inducing apoptosis in cancer cells. This compound effectively inhibits the proliferation of H1975, PC-9, and mutant EGFR cells including BaF3-EGFRL858R/T790M/C797S and BaF3–C797S/Del19/T790M, with IC50 values of 13 nM, 19 nM, 1.2 nM, and 1.3 nM respectively. Additionally, EGFR-IN-117 demonstrates anti-tumor activity in mouse models.Formule :C25H30BrN7O2SCouleur et forme :SolidMasse moléculaire :572.52Icotinib
CAS :Icotinib (Conmana) is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity.Formule :C22H21N3O4Degré de pureté :99.76% - 99.94%Couleur et forme :SolidMasse moléculaire :391.42AD1058
CAS :AD1058 is a selective ATR inhibitor that crosses the blood-brain barrier with in vivo anticancer activity, used in the study of brain and CNS metastasis.Formule :C19H20N6O3SDegré de pureté :98.24%Couleur et forme :SolidMasse moléculaire :412.47Ref: TM-T200105
1mg73,00€5mg160,00€10mg250,00€25mg537,00€50mg827,00€100mg1.108,00€200mg1.485,00€1mL*10mM (DMSO)170,00€EGFR-IN-109
CAS :EGFR-IN-109 (compound 4), an EGFR inhibitor, displays IC 50 values of 25.8 nM for EGFR WT and 182.3 nM for EGFR T790M. This compound halts the growth of cancer cells at the G2/M phase and triggers both early and late apoptosis. It is applicable in cancer research [1].Formule :C12H16N4OSCouleur et forme :SolidMasse moléculaire :264.35HVH-2930
CAS :HVH-2930 is an inhibitor of Heat Shock Protein 90 (HSP90). It suppresses the cell viability of BT474 (Trastuzumab sensitive) and JIMT-1 (Trastuzumab resistant) by downregulating HSP90 client proteins such as HER2, p-HER2, AKT, p-AKT, cyclin D1, and survivin, with IC50 values of 6.86 μM and 4.42 μM, respectively. Additionally, HVH-2930 demonstrates antitumor efficacy in a mouse model and exhibits favorable pharmacokinetic properties in vivo.Formule :C29H36N4O3Couleur et forme :SolidMasse moléculaire :488.62IGF-1R modulator 1
CAS :IGF-1Rmodulator 1 (Example 5) is an IGF-1R modulator featuring an EC50 of 0.29 μM (FGFR1), 0.25 μM (IGF1R), 0.34 μM (TrkA), and 0.39 μM (TrkB). This compound is useful in research on diseases characterized by impaired signaling of neurotrophic and/or other trophic factors, such as Alzheimer's disease.Formule :C22H17N3O4Couleur et forme :SolidMasse moléculaire :387.39


